Who we are
Viomedo is the leading clinical trial platform in the German-speaking DACH region. Together with patients, patient advocacy groups and physicians, we support leading research institutions, life sciences companies and CROs with their clinical research.
Viomedo's customers include the top pharmas, biotechs and CROs
Viomedo Solutions
The number of patients that an average site enrolls is continuously declining. At the same time, competition for patients is increasing as more trials are being conducted across indications. Viomedo helps you in your recruitment efforts, enrolls patients that are beyond the reach of the selected sites and engages patients on a broad basis.
Patient Recruitment
We reach and enroll new patients effectively by using our unique distribution network, data and technology.
Learn MorePortfolio Accessibility
We make your pipeline accessible to patients and medical professionals in Germany and Austria.
Learn MoreData Services
We deliver intelligence on trials, sites and patient populations answering questions on feasibility and startup.
Viomedo Advantages
Over 300.000 patients have
used Viomedo in the second half
of 2017
Approval granted by over
15 ECs / IRBs in Germany and
Austria
Viomedo has partnered with
12 patient organizations spanning
several
indications
Over 600 sites in Germany
and Austria have used
Viomedo
Viomedo provides access
to over 200 indications
Our team combines over
40 years of experience in
medical research